Amylyx Pharmaceuticals (AMLX) Property, Plant & Equipment (Net) (2021 - 2026)
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Amylyx Pharmaceuticals | 3.69 Bn | 3.69 Bn | - | 199,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 445,000.00 |
| Mar 31, 2025 | 816,000.00 |
| Dec 31, 2024 | 961,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 2.76 Mn |
| Jun 30, 2023 | 2.64 Mn |
| Mar 31, 2023 | 2.56 Mn |
| Dec 31, 2022 | 2.61 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 474,000.00 |